TG Therapeutics | TGTX - Current Assets

Tg Therapeutics reported $168.27M in Current Assets for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Current Assets Change
Amgen AMGN:US USD 22.19B 1.88B
Ardelyx ARDX:US USD 153.6M 33.73M
Arrowhead Research ARWR:US USD 575M 169.7M
Bayer BAYN:GR EUR 37.76B 652M
Biogen BIIB:US USD 9.79B 25.4M
Corcept Therapeutics CORT:US USD 499.25M 46.85M
Curis CRIS:US USD 92.12M 13.6M
Dynavax Technologies DVAX:US USD 916.98M 15.96M
Gilead Sciences GILD:US USD 15.23B 1.67B
Infinity Pharmaceuticals INFI:US USD 49.35M 10.26M
Intercept Pharmaceuticals ICPT:US USD 540.13M 5.24M
Karyopharm Therapeutics KPTI:US USD 356.48M 133.8M
Novartis NOVN:VX USD 36.91B 44M
Novavax NVAX:US USD 1.7B 56.57M
Ptc Therapeutics PTCT:US USD 693.78M 176.52M
Puma Biotechnology PBYI:US USD 134.28M 11.93M
Regeneron Pharmaceuticals REGN:US USD 22.06B 6.64B
Roche Holding ROG:VX 33.82B 3.5B
Spectrum Pharmaceuticals SPPI:US USD 112.98M 39.4M
Tg Therapeutics TGTX:US USD 168.27M 14.65M
Verastem VSTM:US USD 92.87M 15.89M
Vertex Pharmaceuticals VRTX:US USD 12.68B 410.3M
Ziopharm Oncology ZIOP:US USD 53.8M 1.71M